These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11900863

  • 1. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
    Malawska B, Kulig K, Filipek B, Sapa J, Maciag D, Zygmunt M, Antkiewicz-Michaluk L.
    Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
    [Abstract] [Full Text] [Related]

  • 2. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
    Filipek B, Sapa J, Malawska B, Kulig K, Antkiewicz-Michaluk L.
    Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B.
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
    Malawska B, Kulig K, Gippert A, Filipek B, Sapa J, Maciag D.
    Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K, Sapa J, Maciag D, Filipek B, Malawska B.
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
    Kulig K, Spieces C, Sapa J, Caspers C, Filipek B, Malawska B.
    Pharmacol Rep; 2010 Sep; 62(1):68-85. PubMed ID: 20360617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
    Sapa J, Filipek B, Nowiński L.
    Pharmacol Rep; 2011 Sep; 63(2):455-63. PubMed ID: 21602601
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J, Nowaczyk A, Kulig K.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):13-25. PubMed ID: 20949258
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
    Dylag T, Zygmunt M, Maciag D, Handzlik J, Bednarski M, Filipek B, Kieć-Kononowicz K.
    Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J.
    Acta Pol Pharm; 2010 Dec; 67(5):537-42. PubMed ID: 20873423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H, Szkaradek N, Kubacka M, Bednarski M, Filipek B, Cegla M, Szneler E.
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H, Librowski T, Cegła M, Erdoğan C, Sahin NO.
    Acta Pol Pharm; 2008 Feb; 65(3):383-90. PubMed ID: 18646559
    [Abstract] [Full Text] [Related]

  • 20. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
    Marona H, Szkaradek N, Rapacz A, Filipek B, Dybała M, Siwek A, Cegła M, Szneler E.
    Bioorg Med Chem; 2009 Feb 01; 17(3):1345-52. PubMed ID: 19131251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.